158 related articles for article (PubMed ID: 31362807)
1. Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016.
Ireland G; Mandal S; Hickman M; Ramsay M; Harris R; Simmons R
Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362807
[TBL] [Abstract][Full Text] [Related]
2. Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017.
Ireland G; Simmons R; Hickman M; Ramsay M; Sabin C; Mandal S
Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615597
[TBL] [Abstract][Full Text] [Related]
3. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
Hamill V; Wong S; Benselin J; Krajden M; Hayes PC; Mutimer D; Yu A; Dillon JF; Gelson W; Velásquez García HA; Yeung A; Johnson P; Barclay ST; Alvarez M; Toyoda H; Agarwal K; Fraser A; Bartlett S; Aldersley M; Bathgate A; Binka M; Richardson P; Morling JR; Ryder SD; MacDonald D; Hutchinson S; Barnes E; Guha IN; Irving WL; Janjua NZ; Innes H
BMJ; 2023 Aug; 382():e074001. PubMed ID: 37532284
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
[TBL] [Abstract][Full Text] [Related]
5. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
[TBL] [Abstract][Full Text] [Related]
6. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
[TBL] [Abstract][Full Text] [Related]
7. Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.
Alavi M; Grebely J; Hajarizadeh B; Amin J; Larney S; Law MG; George J; Degenhardt L; Dore GJ
BMC Infect Dis; 2018 May; 18(1):215. PubMed ID: 29743015
[TBL] [Abstract][Full Text] [Related]
8. Causes of death among persons diagnosed with hepatitis C infection in the pre- and post-DAA era in England: A record linkage study.
Simmons R; Ireland G; Ijaz S; Ramsay M; Mandal S;
J Viral Hepat; 2019 Jul; 26(7):873-880. PubMed ID: 30896055
[TBL] [Abstract][Full Text] [Related]
9. Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study.
Ireland G; Simmons R; Hickman M; Eastwood B; Ramsay M; Mandal S
Int J Drug Policy; 2019 Oct; 72():55-60. PubMed ID: 31257040
[TBL] [Abstract][Full Text] [Related]
10. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
[TBL] [Abstract][Full Text] [Related]
11. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.
Krajden M; Cook DA; Wong S; Yu A; Butt ZA; Rossi C; Darvishian M; Alvarez M; Buxton JA; Tyndall M; Janjua NZ
Int J Drug Policy; 2019 Oct; 72():114-122. PubMed ID: 31229445
[TBL] [Abstract][Full Text] [Related]
12. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.
Neal KR; ; Ramsay S; Thomson BJ; Irving WL
Gut; 2007 Aug; 56(8):1098-104. PubMed ID: 17344277
[TBL] [Abstract][Full Text] [Related]
13. Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain.
Juanbeltz R; Pérez-García A; Aguinaga A; Martínez-Baz I; Casado I; Burgui C; Goñi-Esarte S; Repáraz J; Zozaya JM; San Miguel R; Ezpeleta C; Castilla J;
PLoS One; 2018; 13(12):e0208554. PubMed ID: 30513107
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hepatitis C Virus Infection and Treatment on Mortality in the Country of Georgia, 2015-2020.
Gvinjilia L; Baliashvili D; Shadaker S; Averhoff F; Kandelaki L; Kereselidze M; Tsertsvadze T; Chkhartishvili N; Butsashvili M; Metreveli D; Gamkrelidze A; Armstrong PA
Clin Infect Dis; 2023 Aug; 77(3):405-413. PubMed ID: 37099136
[TBL] [Abstract][Full Text] [Related]
15. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
17. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
[TBL] [Abstract][Full Text] [Related]
18. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
19. Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.
Sinn DH; Kang D; Hong YS; Koh KC; Guallar E; Cho J; Gwak GY
PLoS One; 2021; 16(8):e0255624. PubMed ID: 34343200
[TBL] [Abstract][Full Text] [Related]
20. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
